Your browser doesn't support javascript.
loading
Prognostic implications of histological tumor regression (Böhm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma.
Rajkumar, Savithri; Polson, Alexander; Nath, Rahul; Lane, Geoffrey; Sayasneh, Ahmad; Jakes, Adam; Begum, Shahina; Mehra, Gautam.
Afiliación
  • Rajkumar S; Department of Gynaecological Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland. Electronic address: savithri14@gmail.com.
  • Polson A; Department of Pathology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Nath R; Department of Gynaecological Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Lane G; Department of Gynaecological Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Sayasneh A; Department of Gynaecological Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Jakes A; Department of Obstetrics and Gynaecology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Begum S; Department of Women and Children's Health, School of Life Course Sciences, King's College London & King's Health Partners, St Thomas' Hospital, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
  • Mehra G; Department of Gynaecological Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust (GSTT), Westminster Bridge Road, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland.
Gynecol Oncol ; 151(2): 264-268, 2018 11.
Article en En | MEDLINE | ID: mdl-30197060
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Cistadenocarcinoma Seroso / Neoplasias de las Trompas Uterinas Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Cistadenocarcinoma Seroso / Neoplasias de las Trompas Uterinas Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2018 Tipo del documento: Article